Global Pharma Continuous Granulation 麻豆原创 Growth 2024-2030

Publication ID:

LPI10240100

Publication Date:

October 1, 2024

Pages:

124

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturers [2]

Machinery [3]

Industry & Manufacturing [4]

Description:

Pharmaceutical continuous granulation is a process in which the raw material powder is continuously made into particles through a specific process during the pharmaceutical process. This granulation method usually involves multiple steps such as powder mixing, granulation, and drying. All steps are completed in a continuous operation process, rather than in steps like traditional batch granulation. The purpose of pharmaceutical continuous granulation is to improve production efficiency, reduce production costs and improve product quality.
The global Pharma Continuous Granulation market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淧harma Continuous Granulation Industry Forecast鈥� looks at past sales and reviews total world Pharma Continuous Granulation sales in 2023, providing a comprehensive analysis by region and market sector of projected Pharma Continuous Granulation sales for 2024 through 2030. With Pharma Continuous Granulation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharma Continuous Granulation industry.
This Insight Report provides a comprehensive analysis of the global Pharma Continuous Granulation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharma Continuous Granulation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pharma Continuous Granulation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharma Continuous Granulation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharma Continuous Granulation.
United States market for Pharma Continuous Granulation is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Pharma Continuous Granulation is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Pharma Continuous Granulation is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Pharma Continuous Granulation players cover LB Bohle, GEA, LCI, 尝脰顿滨骋贰, Senieer, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharma Continuous Granulation market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Dry Method
Wet Method
Segmentation by Application:
Tablets
Capsules
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
LB Bohle
GEA
LCI
尝脰顿滨骋贰
Senieer
Thermo Fisher Scientific
Syntegon
Gericke
Bepex
EARTHTECHNICA
Glatt
FREUND
Chansemt
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharma Continuous Granulation market?
What factors are driving Pharma Continuous Granulation market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharma Continuous Granulation market opportunities vary by end market size?
How does Pharma Continuous Granulation break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Pharma Continuous Granulation Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Pharma Continuous Granulation by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Pharma Continuous Granulation by Country/Region, 2019, 2023 & 2030
2.2 Pharma Continuous Granulation Segment by Type
2.2.1 Dry Method
2.2.2 Wet Method
2.3 Pharma Continuous Granulation Sales by Type
2.3.1 Global Pharma Continuous Granulation Sales 麻豆原创 Share by Type (2019-2024)
2.3.2 Global Pharma Continuous Granulation Revenue and 麻豆原创 Share by Type (2019-2024)
2.3.3 Global Pharma Continuous Granulation Sale Price by Type (2019-2024)
2.4 Pharma Continuous Granulation Segment by Application
2.4.1 Tablets
2.4.2 Capsules
2.4.3 Others
2.5 Pharma Continuous Granulation Sales by Application
2.5.1 Global Pharma Continuous Granulation Sale 麻豆原创 Share by Application (2019-2024)
2.5.2 Global Pharma Continuous Granulation Revenue and 麻豆原创 Share by Application (2019-2024)
2.5.3 Global Pharma Continuous Granulation Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Pharma Continuous Granulation Breakdown Data by Company
3.1.1 Global Pharma Continuous Granulation Annual Sales by Company (2019-2024)
3.1.2 Global Pharma Continuous Granulation Sales 麻豆原创 Share by Company (2019-2024)
3.2 Global Pharma Continuous Granulation Annual Revenue by Company (2019-2024)
3.2.1 Global Pharma Continuous Granulation Revenue by Company (2019-2024)
3.2.2 Global Pharma Continuous Granulation Revenue 麻豆原创 Share by Company (2019-2024)
3.3 Global Pharma Continuous Granulation Sale Price by Company
3.4 Key Manufacturers Pharma Continuous Granulation Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharma Continuous Granulation Product Location Distribution
3.4.2 Players Pharma Continuous Granulation Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Pharma Continuous Granulation by Geographic Region
4.1 World Historic Pharma Continuous Granulation 麻豆原创 Size by Geographic Region (2019-2024)
4.1.1 Global Pharma Continuous Granulation Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Pharma Continuous Granulation Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Pharma Continuous Granulation 麻豆原创 Size by Country/Region (2019-2024)
4.2.1 Global Pharma Continuous Granulation Annual Sales by Country/Region (2019-2024)
4.2.2 Global Pharma Continuous Granulation Annual Revenue by Country/Region (2019-2024)
4.3 Americas Pharma Continuous Granulation Sales Growth
4.4 APAC Pharma Continuous Granulation Sales Growth
4.5 Europe Pharma Continuous Granulation Sales Growth
4.6 Middle East & Africa Pharma Continuous Granulation Sales Growth
5 Americas
5.1 Americas Pharma Continuous Granulation Sales by Country
5.1.1 Americas Pharma Continuous Granulation Sales by Country (2019-2024)
5.1.2 Americas Pharma Continuous Granulation Revenue by Country (2019-2024)
5.2 Americas Pharma Continuous Granulation Sales by Type (2019-2024)
5.3 Americas Pharma Continuous Granulation Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharma Continuous Granulation Sales by Region
6.1.1 APAC Pharma Continuous Granulation Sales by Region (2019-2024)
6.1.2 APAC Pharma Continuous Granulation Revenue by Region (2019-2024)
6.2 APAC Pharma Continuous Granulation Sales by Type (2019-2024)
6.3 APAC Pharma Continuous Granulation Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pharma Continuous Granulation by Country
7.1.1 Europe Pharma Continuous Granulation Sales by Country (2019-2024)
7.1.2 Europe Pharma Continuous Granulation Revenue by Country (2019-2024)
7.2 Europe Pharma Continuous Granulation Sales by Type (2019-2024)
7.3 Europe Pharma Continuous Granulation Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharma Continuous Granulation by Country
8.1.1 Middle East & Africa Pharma Continuous Granulation Sales by Country (2019-2024)
8.1.2 Middle East & Africa Pharma Continuous Granulation Revenue by Country (2019-2024)
8.2 Middle East & Africa Pharma Continuous Granulation Sales by Type (2019-2024)
8.3 Middle East & Africa Pharma Continuous Granulation Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharma Continuous Granulation
10.3 Manufacturing Process Analysis of Pharma Continuous Granulation
10.4 Industry Chain Structure of Pharma Continuous Granulation
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharma Continuous Granulation Distributors
11.3 Pharma Continuous Granulation Customer
12 World Forecast Review for Pharma Continuous Granulation by Geographic Region
12.1 Global Pharma Continuous Granulation 麻豆原创 Size Forecast by Region
12.1.1 Global Pharma Continuous Granulation Forecast by Region (2025-2030)
12.1.2 Global Pharma Continuous Granulation Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Pharma Continuous Granulation Forecast by Type (2025-2030)
12.7 Global Pharma Continuous Granulation Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 LB Bohle
13.1.1 LB Bohle Company Information
13.1.2 LB Bohle Pharma Continuous Granulation Product Portfolios and Specifications
13.1.3 LB Bohle Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 LB Bohle Main Business Overview
13.1.5 LB Bohle Latest Developments
13.2 GEA
13.2.1 GEA Company Information
13.2.2 GEA Pharma Continuous Granulation Product Portfolios and Specifications
13.2.3 GEA Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GEA Main Business Overview
13.2.5 GEA Latest Developments
13.3 LCI
13.3.1 LCI Company Information
13.3.2 LCI Pharma Continuous Granulation Product Portfolios and Specifications
13.3.3 LCI Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 LCI Main Business Overview
13.3.5 LCI Latest Developments
13.4 尝脰顿滨骋贰
13.4.1 尝脰顿滨骋贰 Company Information
13.4.2 尝脰顿滨骋贰 Pharma Continuous Granulation Product Portfolios and Specifications
13.4.3 尝脰顿滨骋贰 Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 尝脰顿滨骋贰 Main Business Overview
13.4.5 尝脰顿滨骋贰 Latest Developments
13.5 Senieer
13.5.1 Senieer Company Information
13.5.2 Senieer Pharma Continuous Granulation Product Portfolios and Specifications
13.5.3 Senieer Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Senieer Main Business Overview
13.5.5 Senieer Latest Developments
13.6 Thermo Fisher Scientific
13.6.1 Thermo Fisher Scientific Company Information
13.6.2 Thermo Fisher Scientific Pharma Continuous Granulation Product Portfolios and Specifications
13.6.3 Thermo Fisher Scientific Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Thermo Fisher Scientific Main Business Overview
13.6.5 Thermo Fisher Scientific Latest Developments
13.7 Syntegon
13.7.1 Syntegon Company Information
13.7.2 Syntegon Pharma Continuous Granulation Product Portfolios and Specifications
13.7.3 Syntegon Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Syntegon Main Business Overview
13.7.5 Syntegon Latest Developments
13.8 Gericke
13.8.1 Gericke Company Information
13.8.2 Gericke Pharma Continuous Granulation Product Portfolios and Specifications
13.8.3 Gericke Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Gericke Main Business Overview
13.8.5 Gericke Latest Developments
13.9 Bepex
13.9.1 Bepex Company Information
13.9.2 Bepex Pharma Continuous Granulation Product Portfolios and Specifications
13.9.3 Bepex Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Bepex Main Business Overview
13.9.5 Bepex Latest Developments
13.10 EARTHTECHNICA
13.10.1 EARTHTECHNICA Company Information
13.10.2 EARTHTECHNICA Pharma Continuous Granulation Product Portfolios and Specifications
13.10.3 EARTHTECHNICA Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 EARTHTECHNICA Main Business Overview
13.10.5 EARTHTECHNICA Latest Developments
13.11 Glatt
13.11.1 Glatt Company Information
13.11.2 Glatt Pharma Continuous Granulation Product Portfolios and Specifications
13.11.3 Glatt Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Glatt Main Business Overview
13.11.5 Glatt Latest Developments
13.12 FREUND
13.12.1 FREUND Company Information
13.12.2 FREUND Pharma Continuous Granulation Product Portfolios and Specifications
13.12.3 FREUND Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 FREUND Main Business Overview
13.12.5 FREUND Latest Developments
13.13 Chansemt
13.13.1 Chansemt Company Information
13.13.2 Chansemt Pharma Continuous Granulation Product Portfolios and Specifications
13.13.3 Chansemt Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Chansemt Main Business Overview
13.13.5 Chansemt Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.